Skip to main content

Market Overview

Sorrento Therapeutics Could IPO Its Scilex Unit

Share:

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) announced it's exploring the possibility of an initial public offering of its majority-owned subsidiary, Scilex Holding.

Scilex Holding is a pharmaceutical company that delivers pain management products.

No decisions have been made at this point on the structure or timing of the possible IPO, and no assurance can be given that an IPO will be pursued or completed.

Sorrento's stock closed Tuesday at $2.99 per share.

 

Related Articles (SRNE)

View Comments and Join the Discussion!

Posted-In: Scilex HoldingNews IPOs

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com